Abstract
The Pit-1/GHF-1 (Pit-1) transcription factor is important for the development of anterior pituitary cells that produce GH and PRL. We examined the expression of Pit-1 mRNA in pituitary tissues from rats and mice. Analysis of pituitaries from normal and GHRH transgenic mice showed that Pit-1 transcripts were readily detected in normal, hyperplastic, and neoplastic pituitaries. A cell line (GHRH-CL1) established from a GhRH transgenic mouse pituitary tumor in our laboratory also expressed Pit-1 mRNA. Normal rat pituitaries and those with estrogen-induced PRL cell hyperplasia expressed Pit-1 mRNA. There was a decrease in Pit-1 mRNA in hyperplastic rat pituitaries concomitant with a decrease In GH mRNA amounts and an increase in PRL mRNA amounts after estrogen treatment. Similarly, analysis of GH3 cells in vitro showed that estrogen and bFGF modulated PRL but not Pit-1 mRNA levels. Pit-1 mRNA was localized by combined in situ hybridization and immunohistochemistry to predominantly GH and PRL cells, although some TSH and LH cells in the rat pituitary also expressed Pit-1 mRNA, indicating wide distribution of the mRNA for this transcription factor in various anterior pituitary cell types. Analysis of cell proliferation in normal rat pituitary and GH3 cells revealed that estrogen and bFGF stimulated cell proliferation in normal pituitaries but inhibited proliferation in GH3 cells, whereas Pit-1 transcripts remained unchanged in both groups of cultured cells. These results indicate that Pit-1 mRNA is readily detected in normal, hyperplastic, and neoplastic rodent pituitaries. Changes in Pit-1 mRNA amounts appear to correlate more closely with changes in GH than PRL mRNA levels in cultured pituitary cells.Endocr Pathol 4:146–154, 1993.
Similar content being viewed by others
References
Asa SL, Kovacs K, Stcfancau L, Horvath E, Billcstrup N, Gonzalcz-Manchon C, Vale W. Pituitary adenomas in mice transgenic for growth hormone releasing hormones. Endocrinology 131:2083–2089, 1992.
Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, Vale W. Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Proc Soc Exp Biol Med 193:232–235, 1990.
Brar AK, Brinster RL, Frohman LA. Immunohistochemical analysis of human growth hormone-releasing hormone gene expression in transgenic mice. Endocrinology 125:801–809, 1989.
Camper SA, Saunders TL, Katz RW, Reeves RH. The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 8:586–590, 1990.
Castrillo JL, Bodner M, Karin M. Purification of growth hormone-specific transcription factor GHF-1 containing homeobox. Science 243:814–817, 1989.
Castrillo JL, Theill LE, Karin M. Function of the homeodomain protein GHF-1 in pituitary cell proliferation. Science 253:197–199, 1991.
Chen R, Ingraham HA, Treacy MN, Albert VR, Wilson L, Rosenfeld MG. Autoregulation of Pit-1 gene expression is mediated by two cis-active elements. Nature 346:583–586, 1990.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987.
Delidow BC, Billis WM, Agarwal P, White BA. Inhibition of prolactin gene transcription by transforming growth factor B in GH3 cells. Mol Endocrinol 5:1716–1722, 1991.
De Nicola AF, von Lawzewitsch I, Kaplan SE, Libertun C. Biochemical and ultrastructural studies on estrogen-induced pituitary tumors in F344 rats. J Natl Cancer Inst 61:753–763, 1978.
Dolle P, Castrillo JL, Theill LE, Deennck T, Ellisman M, Karin M. Expression GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 60:809–820
Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13, 1983.
Frohman LA, Downs TR, Kashio Y, Brinster RL. Tissue distribution and molecular heterogeneity of human growth hormone-releasing factor in the transgenic mouse. Endocrinology 127:2149–2156, 1990.
Furth J, Nakane Pk, Pasteels JL. Tumours of the pituitary gland. In: Tursov VS, ed. Pathology of tumours in laboratory animals, Vol. I: tumours of the rat, part 2. Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer, 1976:201–237.
Furth J, Ueda G, Clifton KH. The pathophysiology of pituitaries and their tumors: methodological advances. Methods Cancer Res 10:210–277, 1973.
Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413–416, 1985.
Holtzman S, Stone JP, Shellabarger CJ. Influence of diethystilbestrol treatment on prolactin cells of female ACI and Sprague-Dawley rats. Cancer Res 39:779–784, 1979.
Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG. A tissuespecific transcription factor containing a homeodomain specifies a pituitary pheno-type. Cell 55:519–529, 1988.
Jin L, Kulig E, Fields K, Camper SA, Lloyd RV. Regulation of PRL and Pit-1 expression in normal and neoplastic rat pituitary cells by FGF and estrogen. Presented at the Endocrine Society 73rd Annual Meeting, Washington, DC, June 19–22, 1991:169.
Kim KE, Day RN, Maurer RA. Functional analysis of the interaction of a tissue-specific factor with an upstream enhancer element of the rat prolactin gene. Mol Endocrinol 2:1374–1381, 1988.
Konzak KE, Moore DD. Functional iso-forms of Pit-1 generated by alterative messenger RNA splicing. Mol Endocrinol 6:241–247, 1992.
Lew D, Brady H, Klausing K, Yaginuma K, Theill LE, Stauber C, Karin M, Mellon PL. GHF-1 promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Gene Dev 7:683–693, 1993.
Li S, Crenshaw EB III, Rawson Ej, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 347:528–533, 1990.
Lin C, Lin S-C, Chang C-P, Rosenfeld MG. Pit-1 dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360:765–768, 1992.
Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study. Am J Pathol 113:198–206, 1983.
Lloyd RV. Tumours of the pituitary gland In: Turusov VS, Mohr V. Pathology of tumours in Laboratory animals, Vol 1. Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer, 1990: 499–537.
Lloyd RV, Cano M, Landefeld TD. The effects of estrogens on tumor growth and on prolactin and growth hormone mRNA expression in rat pituitary tissues. Am J Pathol 133:397–406, 1988.
Lloyd RV, Jin L, Chang A, Kulig E, Camper SA, Ross BD, Down TR, Frohman LA. Morphologic effects of hGRH gene expression on the pituitary, liver and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. Am J Pathol 141:895–906, 1992.
Lloyd RV, Landefeld TD, Maslar I, Frohman LA. Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am J Pathol 118:379–386, 1985.
Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612, 1988.
Osamura RY, Oda K, Utsunomiya H, Inada K, Umcmura S, Shibuya M, Katakami H, Voss JW, Mayo KE, Roscnfeld MG. Immunohistochemical expression of Pit-1 protein in pituitary glands of human GRF transgenic mice: its relationship with hormonal expression. Endocrine J 40:133–139, 1993.
Pfaffle RW, Di Mattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118–1121, 1992.
Phelps C, Hymer WC. Characterization of estrogen-induced adenohypophyseal tumors in the Fischer 344 rat. Neuroendocrinology 37:23–31, 1983.
Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisoford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115–1118, 1992.
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
Simmons PM, Voss JW, Ingraham HA, Hollowy JM, Groide RS, Rosenfeld MG, Swanson LW. Pituitary cell phenotype involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Gene Dev 4:695–711, 1990.
Song JY, Jin L, Lloyd RV. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells. Cancer Res 49:1247–1253, 1989.
Steinfelder HJ, Hauser P, Nakayama Y, Radovick S, McClaskey JH, Taylor T, Weintraub BD, Wondisford FE. Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormoneinhibitory element. Proc Natl Acad Sci USA 88:3130–3134, 1991.
Steinfelder HJ, Radovick S, Mroczynski MA, Hauser P, McClaskey JH, Weintraub BD, Wondisford FE. Role of a pituitary specific transcription factor (Pit-1/GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-B subunit gene expression. J Clin Invest 89:409–419, 1992.
Supowit SC, Ramsey T, Thompson EB. Extinction of prolactin gene expression in somatic cell hybrids is correlated with the repression of the pituitary-specific transactivator GHF-1/Pit-1. Mol Endocrinol 6:786–792, 1992.
Tatsumi K-N, Miyai K, Tsugunim N, Kaibe K, Amino N, Mizano Y, Kohno H. Cretinismu with combined hormone deficiency caused by a mutation in the Pit-1 gene. Nature Genet 1:56–58, 1992.
Voss JW, Rosenfeld MG. Anterior pituitary development: short tales from dwarf mice. Cell 70:527–520, 1992.
Wiklund J, Wertz N, Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109:1700–1707, 1981.
Yan GZ, Bancroft C. Mediation by calcium ot thyrotropin-releasing hormone action on the prolactin promoter via transcription factor Pit-1. Mol Endocrinol 5:1488–1497, 1991.
Zhang K, Kulig E, Jin L, Lloyd RV. Effects of estrogen and epidermal growth factor on prolactin and Pit-1 mRNA in GH3 cells. Proc Soc Exp Biol Mol 222:193–200, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lloyd, R.v., Jin, L., Kulig, E. et al. Pit-1/ghf-1 transcription factor expression in rodent pituitaries. Endocr Pathol 4, 146–154 (1993). https://doi.org/10.1007/BF02915303
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02915303